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Abstract 
To fulfill its function, the immune system must detect and interpret a wide variety of signals 
and adjust the magnitude, duration, and specific traits of each response during the complex 
host-parasite relationships in parasitic infections. Inflammation must be tightly regulated since 
uncontrolled inflammation may be as destructive as the triggering stimulus and leads to 
immune-mediated tissue injury. 
During recent years, increasing evidence points to regulatory T cells (Tregs) as key an-
ti-inflammatory cells, critically involved in limiting the inflammatory response. Herein, we 
review the published information on the induction of Tregs and summarize the most recent 
findings on Treg generation in parasitic diseases. 
Key words: regulatory T cells; parasitic infections; inflammation, dendritic cell; regulation; immune 
response; cytokines; malaria; Leishmania; Trypanosoma; Schistosoma, nematodes. 
Regulatory T cells: phenotypes and induc-
tion 
Regulatory T cells (Tregs) play an important role 
in the control of the immune response. Different types 
of Treg cells have been described, and may be classi-
fied  into  two  main  groups:  thymic  and  inducible. 
Thymic or natural Treg cells (nTregs), are produced in 
the thymus and are present in the host’s bloodstream 
before pathogen or damage exposure. Inducible Treg 
cells (iTregs) are those cells that acquire a regulatory 
function in the context of a given infection or a neo-
plastic  process.  Inducible  Treg  cell  populations  in-
clude: T regulatory 1 (Tr1) cells, which secrete IL‑10; T 
helper 3 (Th3) cells,  which secrete TGF-β, and con-
verted Foxp3+ Treg cells [1-3]. This review is focused 
on the induction of CD4+ Tregs, mostly by Foxp3+ 
expression, and on their suppressor activities during 
parasite infections. 
Inducible Treg cells are generated in the periph-
ery  and  exert  their  suppressor  activity  mainly  by 
producing  IL-10,  IL-35,  and  TGF-β  [4,  5].  Initially, 
these iTreg cells are conventional T cells expressing 
low  or  null  levels  of  CD25  (CD25low/-)  [6].  CD25 
expression could be up-regulated according to envi-
ronmental  conditions  [7].  On  the  other  side,  Foxp3 
expression  is  up-regulated  by  signaling  pathways 
initiated  by  T  cell  receptor  (TCR),  co-stimulatory 
molecules, IL-2R, programmed death ligand 1 (PDL1), 
transforming  growth  factor- (TGF-β)  receptor,  and 
Notch [8-10]. In fact, the TCR density on the cell sur-
face and its affinity to the antigen play a key role in 
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Treg  induction.  It  has  been  demonstrated  that  TCR 
stimulation by a strong agonist in low dose resulted in 
maximal induction of Foxp3 in vivo. Also, the density 
and duration of TCR interactions define a cumulative 
TCR stimulation that determines initial Foxp3 induc-
tion [11]. In contrast, high doses of TCR engagement 
in  presence  of  CD28  co-stimulation  induce  NF-κB 
signaling,  which  prevents  Foxp3  induction  in  mice 
[12]. On the other hand, recently it has been demon-
strated  that  CD28  signals  alone,  independently  of 
TCR-mediated stimulatory pathways, are sufficient to 
induce Foxp3 transcription in CD4(+)CD25(-) T cells. 
Additionally, the stimulation of CD28 associated with 
TCR can regulate Foxp3 expression; the authors pro-
pose that, under these conditions, CD28 signals me-
diate Foxp3 trans-activation by nuclear translocation 
of RelA/NF-κB [13, 14]. Furthermore, the presence of 
regulatory  cytokines  like  IL-10,  TGF-β  and  IL-35 
during the priming of T lymphocytes favors regula-
tory T cell generation, function and maintenance (this 
point is discussed later). Most probably, the accumu-
lation of signals that yield a regulatory T cell pheno-
type depend on the molecules expressed on the cell 
surface,  their  interaction  with  environmental  mole-
cules, and the prevalent intracellular signaling. All of 
these  factors  may  in  turn  be  modified  by  infective 
agents as a way to evade immunity. 
In that sense, several mechanisms have been re-
ported  as  involved  in  Treg-mediated  immune  sup-
pression, offering a wide range of possibilities to ex-
hibit their function under different environmental and 
requirement  conditions.  Some  of  these  mechanisms 
are reviewed elsewhere [15]. 
Role of dendritic cells and cytokines in 
Treg induction during the adaptive im-
mune response 
Tregs can be generated by conversion from naïve 
T cells or by expanding the population of pre-existing 
Treg  cells.  The  nTregs  antigen-specificity  issue  re-
mains  controversial  since  they  are  expanded  from 
pre-existing  Tregs.  In  contrast,  Tregs  induced  as  a 
consequence of adaptive immune response are gen-
erally  antigen-specific  [16];  however,  Treg  cells  can 
inhibit responder T cells of unrelated antigen speci-
ficity  [17].  On  the  other  hand,  the  Treg  induction 
pathway depends on the interaction of T cells with 
tolerogenic  dendritic  cells,  anti-inflammatory  cyto-
kines, glucocorticoids, vitamins, or other suppressive 
molecules produced by pathogens [18]. 
Role of dendritic cells 
The  immunological  paradigm  places  fully  ma-
ture dendritic cells (DCs) as immunity inducers. It is 
currently believed that DCs integrate a variety of in-
coming  signals  and  decide  whether  protective  im-
munity or tolerance develops. Mature DCs might be 
crucially involved in the expansion and induction of 
Treg  cells.  In  fact,  conventional  CD4+  cells  become 
either  specific  T  helper  or  T  regulatory  cell  subsets 
depending upon the affinity of their TCR to the anti-
gen,  the  strength  of  the  co-stimulatory  signals  pro-
vided  by  antigen-presenting  cells  (APCs),  and  the 
cytokine milieu (Fig. 1).  
 
 
Figure 1. Different pathways of reg-
ulatory T cell induction. A) Semima-
ture  dendritic  cells  promote  the 
conversion of naïve T cells into Treg 
cells.  B)  Fully  mature  dendritic  cells 
generate  new  antigen-specific  regu-
latory T cells during immune response 
priming. C) Fully mature DCs may be 
crucially involved in the expansion of 
preformed Treg cells. D) Plasmacytoid 
dendritic cells also promote Treg cell 
induction  by  ICOS-L,  TLR9,  TGF- 
and IDO-dependent pathways. 
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In contrast, semimature DCs promote T cell tol-
erance  by  the  conversion  of  naïve  T  cells  into  Treg 
cells.  The  absence  of  inflammation  arrests  dendritic 
cells into a semimature state (iDC). iDCs are charac-
terized by the expression of MHC II, a high phagocy-
tosis capacity, and low CD80/CD86 expression; they 
produce IL-10, but neither IL-12 nor TNFα. The ina-
bility  of  producing  IL-12p70  in  bioactive  amounts 
together with IL-10 generates a unique phenotype of 
semimature DC that induces Treg cells (Fig. 1) [19]. In 
turn,  these  newly  formed  Treg  cells  induce  a  sup-
pressive environment. 
Role of cytokines 
IL-10 
IL-10 plays a role in Treg increase and mainte-
nance [20]. The role of IL-10 in regulatory T cell in-
duction  probably  involves  several  events:  in  APC, 
IL-10 reduces antigen presentation by trapping pep-
tide-loaded major histocompatibility complex type II 
(MHCII)  molecules,  reducing  the  co-stimulatory 
molecules  CD80/CD86  expression,  and  destabilizes 
cytokine mRNAs. Additionally, it has been reported 
that high levels of CD40, CD86, and PD-L1 in APC 
favor de novo induction of Tr1 cells [21]. 
In turn, IL-10 conditions CD4+ T cells to become 
unresponsive to antigens, and these cells lose the ca-
pacity to produce cytokines, probably by induction of 
suppressors  of  cytokine  signaling  (SOCS-1  and  -3) 
[22]. Other IL-10 effects on peripheral generation of 
Treg  cells  may  be  mediated  by  activation  of  the 
Notch-dependent  signaling  pathway.  Transgenic 
mice  carrying  the  constitutively  active  intracellular 
domain of Notch3 in thymocytes and T cells fail to 
develop experimental autoimmune diabetes. The ina-
bility to develop the disease is associated with an in-
crease of CD4+CD25+ Treg cells. In fact, an accumu-
lation of Tregs in lymphoid organs and pancreas in-
filtrates is observed. This accumulation is paralleled 
with an increased expression of IL-4 and IL-10 [23]. 
Furthermore,  the  stimulation  of  purified  murine 
CD4+ T cells with antigen, anti-CD3 and anti-CD28 
antibodies has proved to induce a transient increase in 
Notch ligand and receptor expression [24]. Probably, 
Notch has a key role in boosting the differentiation 
and possibly the function of Treg cells [23]. Likewise, 
in  naïve  mouse  CD4+  T  cells,  Notch  induces  IL-10 
production  via  a  signal  transducer  and  activator  of 
transcription 4 (STAT4). IL-10 could act as a positive 
autocrine  factor  in  the  development  of 
IL-10-producing Tregs [25]. 
An indirect mechanism of action of IL-10 in the 
generation of suppressor cells occurs through CD4+ 
anergic induction. In one pathway, IL-10 induces an-
ergy in CD4+ T cells [26]; in another pathway, treat-
ment  of  dendritic  cells  with  IL-10  yields  anergic  T 
lymphocytes  [27,  28].  These  anergic  T  cells  act  as 
suppressor  cells  by  competing  with  other  anti-
gen-stimulated T cells for the membrane of APCs and 
for locally produced IL-2 [20]. 
TGF-β 
Evidence of the in vivo effect of TGF-β in a Treg 
cell  pool  expansion  was  described  in  diabetic  mice 
stimulated with TGF-β. In these mice, TGF-β inhibited 
autoimmune type I diabetes development, in addition 
to an increase in the Treg frequency in pancreatic in-
traislets. These cells showed high levels of intracellu-
lar CTLA-4 and Foxp3 expression [29]. Early studies 
in human T cells demonstrated that TGF-β was nec-
essary to induce Tregs. Stimulation of human CD4+ 
cells with TGF-β increases the number of Tregs and 
intracellular  expression  of  CD25  and  CTLA-4.  This 
expansion was due to both an increased proliferation 
and  the  protection  of  these  cells  from  activa-
tion-induced apoptosis [30]. 
TGF-β promotes the induction of Treg cells ac-
companied  by  an  increase  in  Foxp3  expression.  In 
mice, it has been demonstrated that TGF-β is able to 
convert  CD4+CD25-Foxp3-  non-Tregs  into 
CD4+CD25+Foxp3+  Tregs.  Evidence  for  the  role  of 
TGF-β was collected in Foxp3-mRFP mice, in which 
Foxp3-expressing  cells  were  marked  by  messenger 
red fluorescent protein (mRFP) expression. Upon TCR 
engagement,  TGF-β  induced  de  novo  Foxp3  expres-
sion.  Furthermore,  only  Foxp3+CD4+  cells  but  not 
their  Foxp3-CD4+  counterparts  showed  regulatory 
activity [31]. Also, in an independent study, Zhang et 
al. reported that engagement to TCR and CTLA-4 de-
livers a specific signal which cooperates with TGF-β 
signaling  molecules  to  initiate  Smad  signaling  and 
recruits co-activators to activate Foxp3 expression [8, 
32]. 
Foxp3 regulation and induction mechanisms are 
currently  being  elucidated.  Fantini  et  al.  suggested 
that TGF-β may induce Foxp3 directly by binding to 
the inhibitory Smad7 promoter region to turn off its 
expression.  Thus,  TGF-β  might  produce  a  feedback 
regulation  of  TGF-β  signaling  that  may  result  in  a 
cumulative Foxp3 expression, facilitating the conver-
sion of T cells into Tregs [33]. 
Foxp3  transcription  is  a  key  factor  in  Treg  in-
duction, differentiation, function and survival. foxp3 
gene expression is controlled by a core promoter and 
at least three distal enhancers. During T cell activa-
tion, a number of transcription factors (NFAT, AP1, 
CREB, SP1, c-Rel, RUNX, TIEG1, RAR Stat5, ATF, and Int. J. Biol. Sci. 2011, 7 
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Smad  3)  bind  to  conserved  noncoding  sequences 
(CNS) in the promoter and in intron 2 [34]. In fact, the 
5’ and 3’ CNS in intron 2 serve as enhancer sites. The 
formation  of  a  Foxp3-specific  “enhanceosome”  con-
taining nuclear factor-kB, c-Rel, NFATc2, p65, Smad3, 
and CREB as FOXP3 expression inducers [35-38] has 
been identified. Recent studies indicate that murine 
TGF-β  drives  Foxp3  expression,  probably  in  two 
ways: 1) through the induction of activated Smad3, as 
it initially binds to an enhancer site in intron 2 of foxp3 
gene and then interacts with nuclear factors to form 
an  “enhanceosome”,  which  binds  to  the  foxp3  pro-
moter, resulting in Foxp3 transcription; 2) TGF-β in-
duces increased H4 histone acetylation in the region 
of NFAT/Smad binding; this increases the accessibil-
ity of various transcription factors and facilitates the 
FOXP3 promoter activity [38]. 
Notably,  the  relationship  between  TGF-β  and 
CTLA-4 is essential for Treg induction. Zheng et al. 
have demonstrated that TGF-β is required to induce 
Foxp3  expression,  but  in  CTLA-4-/-  deficient  mice 
TGF-β stimulation is not able to convert CD4+CD25- 
cells  into  Tregs.  This  group  has  also  demonstrated 
that CTLA-4 ligation to CD80 shortly after T cell acti-
vation enables TGF-β to induce CD4+CD25- cells to 
expressing FoxP3 and developing suppressor activity. 
Additionally, Foxp3 has been reported to up-regulate 
CTLA-4  expression;  thus,  a 
TGF-β/CTLA-4/FoxP3/CTLA-4 positive loop may be 
vital for the induction and maintenance of regulatory 
T cells [32]. 
It was suggested that TGF-β alone is unable to 
mediate Treg cell induction. In fact, the combination 
of IL-2 and TGF-β play different but complementary 
roles in Treg induction. In IL-2 KO mice, Foxp3 ex-
pression cannot be sustained in the periphery; also, 
IL-2 KO T cells stimulated with TGF-β are not able to 
convert  CD4+  T  cells  into  Treg  cells.  Thus,  during 
Treg induction it is likely that TGF-β induces Foxp3 
expression in newly induced Tregs, and that Foxp3 
stability is apparently IL-2-dependent [39]. In agree-
ment with these observations, Foxp3+ Treg induction 
requires the expression of IL2R and TGF-β receptors 
[39, 40]. Additionally, the administration of IL-2 re-
sults  in  the  stabilization  of  Foxp3  expression  in 
TGF-β-induced  Tregs  in  vivo  [41].  Additionally,  an 
indirect effect might take place during Treg induction: 
while IL-2 could promote the growth of these cells, 
TGF-β  would  protect  them  from  activation-induced 
apoptosis [20]. 
Recently, new molecules  have been implied in 
Foxp3 induction by TGF-β. In mucosal tissue, mature 
tolerogenic DCs producing retinoic acid also induce 
Foxp3+ Tregs via a TGF-β-dependent mechanism. In 
fact,  retinoic  acid  enhances  TGF-β  signaling  by  in-
creasing  the  expression  and  phosphorylation  of 
Smad3, and this results in increased Foxp3 expression, 
even in the presence of IL-6 or IL-21 [42]. 
Furthermore, it has been proposed that Activin 
A may contribute to the expansion of peripheral Treg 
cells. Activin A is a pleiotropic TGF-β family member 
and is expressed in response to inflammatory signals. 
Huber  et  al.  reported  that  Activin  A  together  with 
TGF-β1 shows synergistic effects on the Treg conver-
sion rate and seems to be essential for Treg induction 
[43]. 
IL-35 
IL-35 is a heterodimeric cytokine composed by 
an Epstein-Barr virus-induced gene 3 (EBI3) subunit 
plus  the  p35  subunit  of  IL-12.  IL-35  is  a  Treg 
cell-specific cytokine, required for the maximum reg-
ulatory activity of mouse Treg cells in vitro and in vivo 
[4].  Recently,  Collison  and  colleagues  described  a 
newly identified population of CD4+ Treg cells, in-
duced  by  IL-35,  called  “iTR35  cells”.  They  have 
demonstrated that human and mouse CD4+ T cells 
activated  with  beads  coated  with  anti-CD3  and  an-
ti-CD28 antibodies in the presence of IL-35 substan-
tially  up-regulated  EBI3  and  IL12A  mRNA,  which 
encode the two constituents of IL-35. iTR35 did not 
express  Foxp3  or  other  key  suppressive  cytokines 
(IL-10  or  TGF-β);  thus,  the  proposed  phenotype  is 
CD4+Foxp3−Ebi3+p35+IL-10−TGF-β−.  iTR35  medi-
ated suppression exclusively via IL-35 and seemingly 
independently  of  IL-10 and TGF-β. iTR35 expresses 
CTLA-4 in a relatively low percentage (<15%), and its 
function is not yet clear. Finally, these authors showed 
the  regulatory  capacity  of  iTR35  by  restoration  of 
immune  homeostasis  and  preventing  autoimmunity 
in Foxp3–/– mice, preventing EAE, controlling T cell 
proliferation in a lymphopenic setting, and limiting 
the pathogenesis during experimental colitis [44]. 
Role of glucocorticoids in Treg cell induc-
tion 
Glucocorticoids (GCs) inhibit the ability of APCs 
to  stimulate  effector  T  lymphocytes  and  favor  Treg 
cell induction. Emilie et al. showed that GCs and IL-10 
stimulate  the  production  of  an  intracellular  factor 
called  glucocorticoid-induced  leucine  zipper  (GILZ) 
in monocytes/macrophages and in human DCs [45]. 
GILZ prevents the expression of activation molecules 
such  as  MHC  II,  CD80,  CD86,  and  CD83,  and  in-
flammatory chemokines. Besides, GILZ stimulates the 
expression  of  immunoregulatory  molecules  like 
B7-H1/CD274, ILT3/CD85k and IL-10 [46]. Hamdi et 
al. showed that GILZ-expressing DCs stimulate in T Int. J. Biol. Sci. 2011, 7 
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lymphocytes  the  expression  of  the  Tregs  markers 
CD25hi, Foxp3, and CTLA-4. Induced Tregs are able 
to produce IL-10 and inhibit T CD4+ cell proliferation 
in an antigen-specific manner. In fact, IL-10 produc-
tion by Tregs is essential for suppression. The mecha-
nism  probably  implies  two  different  ways:  1)  IL-10 
acts as a growth factor for Tregs, and 2) IL-10 con-
tributes to their suppressive functions [47, 48]. 
The concomitant administration of vitamins and 
dexamethasone induces differentiation of regulatory 
T cells from naïve T CD4+ cells in both humans and 
mice. These Treg cells are characterized by: (a) IL-10 
production, (b) attenuated secretion of IL-2 and IFN, 
(c) lack of induction of the Th1 or Th2 phenotype, and 
(d) significant antigen-specific and non-specific sup-
pression  of  T  cell  proliferation.  The  mechanism  de-
scribed may imply a direct effect on dendritic cells, as 
mentioned above [49-53]. 
Another mechanism of Treg cell induction may 
involve  a  direct  effect  of  vitamin  D3  and  dexame-
thasone on T cells. Barrat et al. have shown that vita-
min  D-Dex  treatment  induces  the  development  of 
IL-10-producing  T  cells  in  absence  of  APCs.  When 
naïve  CD4  T  cells  were  simultaneously  stimulated 
with vitamin D-Dex, anti-CD3 and anti-CD28, higher 
numbers of IL-10-producing cells were obtained. The 
use  of  anti-IL-10R  mAbs  inhibits  Treg  induction  in 
these APC-free systems. Thus, IL-10 acts as a positive 
autocrine  factor  in  the  development  of 
IL-10-producing Treg cells [54]. This effect could be 
associated to the down-regulation of NF-kB p50 and 
c-Rel protein expression [50, 54, 55]. 
Plasmacytoid dendritic cells in Tregs in-
duction 
Plasmacytoid DCs (pDCs) play distinct roles in 
regulating T cell-mediated adaptive immunity. First-
ly,  pDCs  express  different  PAMS  and  possess  the 
ability to produce large amounts of type-1 IFNs. Also, 
maturing  pDCs  exhibit  the  ability  to  generate 
IL-10-producing  Treg  cells  [56].  These  mechanisms 
are  possibly  mediated  by  indoleamine 
2,3-dioxygenase  (IDO)  and  inducible  T-cell 
co-stimulator  ligand  (ICOS-L),  among  other  mole-
cules  [56,  57].  pDCs  do  not  express  functional  IDO 
constitutively; however, they can be readily activated 
by tolerogenic ligands or by CpG. In fact, binding of 
CpG  to  TLR9  and  CTLA-4-Ig  or  GITR-Ig  to  B7  in 
pDCs  promotes  IDO  protein  expression.  IDO  cata-
lyzes the conversion of tryptophan into kynurenine, a 
critical metabolite involved in the generation of Tregs 
with  potent  cell  suppressor  function  from 
CD4+CD25-  T  cells  [57-59].  Recently  it  has  been 
demonstrated that IDO acts as an intracellular signal 
transducer, in response to TGF-β, to induce a stable 
regulatory phenotype in plasmacytoid dendritic cells. 
These pDCs are able to generate Tregs from naïve T 
cells [60]. 
The role of ICOS-L in Treg generation was elu-
cidated by Ito et al., 2004. They found that naïve pe-
ripheral  CD4  T  cells  co-cultured  with  pDC  in  the 
presence  of  neutralizing  antibodies  against  ICOS-L 
inhibits IL-10 production by Treg cells, but not other 
cytokines such as IFN-γ or TNFα. On the other side, in 
the same study it was shown that the stimulation of 
naïve CD4 T cells with anti-CD3 alone or anti-CD3 in 
the presence of ICOS-L generates Treg cells capable of 
producing high levels of IL-10 but not IL-4 [56]. Fur-
thermore, a specific defect in Treg cell-mediated mu-
cosal tolerance has been observed in ICOS-deficient 
(ICOS−/−) mice [61]. In agreement with this, ICOS-L 
has been previously implicated in the generation of 
IL-10-producing  Treg  cells,  both  in  human  studies 
and mouse disease models [62, 63]. 
Moreover, pDC are not a main APC subset and 
probably this would limit their role in regulatory T 
cell induction. However, the interaction of TLR9 with 
CpG favors pDC suppressor activity, as stated above. 
This may promote a suppressor environment accom-
panied by Treg induction. 
The capacity of parasites to activate TLR9 in pDC 
and thus induce Treg cells as a part of their control 
strategies on the host’s immune response still needs to 
be elucidated. 
Generation of regulatory T cells in parasitic 
infections 
Regulatory T cells help controlling the immune 
response, but in some cases pathogens may promote 
an excessive regulatory control, which allows parasite 
replication  without  restraint  and  compromises  the 
host. The consequence of such control is an enhanced 
pathogen  survival  and,  in  some  cases,  a  long-term 
pathogen  persistence.  Even  though  there  are  clear 
evidences of Treg cell induction during many para-
sitic infections, their role in these parasitoses is not 
well established yet. Herein we discuss some illustra-
tive examples of parasitic infections that involve Tregs 
in their pathogenesis. 
In leishmaniasis 
Parasites of the genus Leishmania are the causa-
tive agents of cutaneous, mucocutaneous or visceral 
leishmaniasis  [64].  Leishmania  sp.  triggers  multiple 
effects on the functions of macrophages and dendritic 
cells that promote immunomodulation of innate im-
mune response and impair their capacity to initiate 
Th1 cell immunity (as discussed in [65]). Int. J. Biol. Sci. 2011, 7 
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It has been suggested that intracellular forms of 
Leishmania (promastigotes and amastigotes) produce 
yet  unknown  molecules  that  promote  an  immuno-
regulatory environment, probably through IL-10 and 
TGF-β. This way, the induction of regulatory T cells 
permit a low-level persistence of the parasite, which 
in turn maintains the immunological stimulus (Table 
1) [66, 67]. In fact, in vivo experiments have suggested 
that transferred CD25- T cells become CD25+. These 
Tregs  are  homed  at  the  parasite  inoculation  site, 
where they promote the infection establishment and 
ensure the long-term survival of the parasite in the 
host [66]. Actually, CD103 expression has been shown 
to be essential for Tregs homing. Genetically suscep-
tible BALB/c mice that lack CD103 become resistant 
to Leishmania major infection, a phenotype associated 
with a poor capacity of Tregs to be retained in the 
infection site (skin) [68]. Conversely, Treg cells accu-
mulate in the lesions of patients with acute cutaneous 
leishmaniasis. These Tregs are functionally suppres-
sive, since they decrease the IFN-γ production. The 
main  suppressive  action  observed  in  intralesional 
Tregs implies IL-10 and IDO [69]. 
Different  authors  have  proposed  that,  during 
infection, the parasite promotes Treg induction, which 
might  also  modulate  effector  T  cells  or  anti-
gen-presenting cell (APC) functions by means of cell 
contact-dependent  mechanisms  [66,  67,  70].  Other 
teams  have  observed  that  lower  CD40  expression 
levels in APC are related to the degree of infection of 
L. donovani. Interestingly, the parasite down-regulates 
CD40 expression and up-regulates IL-10 and TGF-β 
expression in APC during infection. All of these con-
ditions are required for efficient Treg induction [71]. 
Additionally, Leishmania amastigotes can infect den-
dritic cells and down-regulate early innate signaling 
events,  resulting  in  impaired  DC  function  that  in-
cludes lower CD40 and CD83 expression, suppressed 
IL-12p40,  IL-12p70,  and  IL-6  production,  and  in-
creased IL-10 production [70]. 
Recently,  it  has  been  reported  that  Leishmania 
major cutaneous infection stimulated IDO expression 
in local lymph nodes [72]. The known effect of IDO on 
dendritic  cells  suggests  that  this  molecule  could  be 
involved  in  Treg  induction  during  cutaneous  infec-
tion. 
 
Table 1. Regulatory T cells (Tregs) in leishmaniasis 
Parasites  Host  Molecule involved  Cells involved  Role of Tregs in pathogenesis  Ref # 
L. major  Mouse  IL-10  *Tr1  Tregs accumulation favors parasite persistence  [66, 134] 
L. donovani  Mouse  TGF-β  º Th3   Enhance parasite growth and exacerbate infection  [135] 
L. donovani  Human  IL-10  Tr1  Enhance skin lesion  [136] 
L. guyanensis  Human  IL-10, IDO  ‡Tregs   Accumulation in lesions from acute cutaneous leish-
maniasis; Tregs contribute to infection chronicity 
[69, 137] 
L. infantum  Mouse  IL-10, TGF-β  Tr1, Th3  Influence local immune response that favors parasite 
persistence 
[138] 
L. braziliensis  Mouse/Human  IL-10, TGF-β  Tregs   Enhance cutaneous lesions  [139, 
140] 
L. braziliensis  Macaque  IL-10  Tregs   Regulate local immune response  [141] 
*Tr1: IL-10 producing cells, ºTh3:TGF-β producing cells, ‡Tregs: conventional Foxp3+ cells 
 
In schistosomiasis 
Schistosomiasis is one of the most common par-
asitic  infections  worldwide.  Upon  infection,  adult 
parasites migrate to the mesenteric veins, where they 
lay hundreds of eggs per day. Some of these eggs are 
trapped in the liver, gut and other organs, causing a 
vigorous  granulomatose  response  [73].  The  promo-
tion of Tregs could be regarded either as beneficial or 
detrimental for the parasite. This approach to the role 
of Treg cells in schistosomiasis has not been explored 
yet, and deserves further research. We propose two 
hypothetical  possibilities  about  the  role  of  Tregs  in 
schistosomiasis. In one, the immune system itself in-
duces  Tregs  to  control  the  exacerbated  immune  re-
sponse that produce granulomas. Thus, granulomas 
would be useful to eliminate the parasite, since they 
would help locating the eggs and triggering the im-
mune response. As a second possibility, parasite an-
tigens  mediate  Treg  induction  during  granuloma 
formation.  The  fibrosis  promoted  by  collagen  pro-
duction induced by IL-13 [73, 74] supports the first 
possibility. IL-13 could also be directly involved in the 
induction of Treg cells. The engagement of the IL-4R 
alpha-chain by binding cytokines IL-4 and IL-13 was 
identified as an inducer of CD25+ Tregs from periph-
eral naïve CD25-CD4 T cells [75]. Nevertheless, it is 
not known if this IL-13 production during schistoso-
miasis infection is related or not to Treg cell genera-
tion.  Supporting  the  second  possibility,  Treg  cells 
have been associated to egg antigens during Schisto-Int. J. Biol. Sci. 2011, 7 
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some infections in mice [76, 77]. In fact, IL-10-secreting 
CD4+CD25+  cells  isolated  from  granuloma  from 
chronically infected mice can suppress the prolifera-
tion of CD4+ T cells [78, 79]. An alternative approach 
to address the role of Treg cells in granulomas was 
adopted  by  Singh  et al.,  2005,  using  experimentally 
infected  mice  with  Schistosoma mansoni.  They  found 
that granulomatous livers at 8 and 16 weeks after in-
fection  showed  10-  and  30-fold  increases  in  Foxp3 
expression  compared  with  normal  liver.  Also,  the 
percentage of Treg cells in granuloma rose from 12% 
at 8 weeks to 88% at 16 weeks after infection. Retro-
viral transfer of the Foxp3 gene at the onset of granu-
loma formation enhanced Foxp3 expression fourfold 
in granuloma CD4(+) CD25(+) T cells, and strongly 
suppressed  full  granuloma  development  [80].  All 
these data suggest that Schistosoma may be implicated 
in the evolution of granulomas (Table 2). 
In trypanosomiasis 
Trypanosomes are zooflagellate protozoans that 
cause  persistent  infections  accompanied  by  a  pro-
found immunosuppression [81]. Trypanosoma cruzi is 
an intracellular parasite, primarily located in the tis-
sues,  while  African  trypanosomes  are  extracellular 
forms circulating in the blood.  The role of Tregs in 
trypanosomiasis  infection  is  controversial.  On  one 
side,  African  trypanosomiasis  is  characterized  by 
gradual  expansions  of  the  total  number  of  Tregs, 
starting  at  parasite  establishment  and  continuing 
during the chronic stages of the disease, which favors 
parasite tolerance (Table 3) [82, 83]. On the other side, 
Tregs have a limited role on Trypanosoma cruzi path-
ogenesis [84, 85]. In fact, depletion of Treg cells during 
acute  and  chronic  infection  neither  improved  nor 
worsened the course of the infection and the immun-
ity involved [86]. However, it is important to note that 
T.  cruzi  and  African  trypanosomes  are  completely 
different, and that immune response induced by an 
extracellular or by an intracellular parasite will trigger 
different effector mechanisms. Thus, the role of Tregs 
in trypanosomiasis may depend on factors such as the 
parasite biology, the environment, and the host im-
mune response. 
 
Table 2. Regulatory T cells (Tregs) in schistosomiasis 
Parasites  Host  Molecule involved  Cells involved  Role of Tregs in pathogenesis  Ref # 
S. mansoni  Mouse  IL-10  *Tr1, ‡Tregs  Suppress Th1 and Th2 response and increase the sus-
ceptibility to infection 
[78, 79] 
S. mansoni  Mouse    Tregs   Regulate immune response, favoring eggs survival  [133] 
S. japonicum  Mouse  IL-10, TGF-β  Tregs   Regulate immune response, favoring parasite survival  [142] 
S. mansoni  Mouse  CD103, GITR, OX40, 
CTLA-4 
Tregs   Limit and control granuloma growth  [143] 
S. japonicum  Mouse  IL-10  Tregs  Promote worm burden  [144] 
*Tr1: IL-10 producing cells, ‡Tregs: conventional Foxp3+ cells 
 
Table 3. Regulatory T cells (Tregs) in trypanosomiasis 
Parasites  Host  Molecule involved  Cells involved  Role of Tregs in pathogenesis  Ref # 
T. congolese  Mouse  IL-10  ‡Tregs, *Tr1, ∞nTregs  Down-regulate the Th1 response and preserve host 
parasite clearance 
[83] 
T. cruzi  Human  IL-10, CTLA-4  Tregs,Tr1  Control early stages and favor the disease progression  [145] 
T. congolese  Mouse    Tregs   Prevent early protective response  [82] 
T. cruzi  Mouse  GITR  Tregs  Control inflammation  [85, 140] 
T. cruzi  Mouse    Tregs  Neither improve nor worsen the outcome of immune 
response 
[86] 
*Tr1: IL-10 producing cells, ‡Tregs: conventional Foxp3+ cells, ∞nTregs: Natural Tregs 
 
 
On  the  other  hand,  Treg  generation  during 
trypanosome infection is supported by multiple evi-
dences. The mechanism may imply a default in DC 
activation or a specific cytokine balance to an immu-
nosuppressive  environment  [87].  At  early  stages  of 
infection,  Guilliams  et al.,  2007,  observed  that  Treg 
population is expanded in spleen and liver of mice 
infected by T. congolense. These cells produced IL-10 
and mediated suppression of the type-1 inflammatory 
immune response  [83]. Probably, the effect of these Int. J. Biol. Sci. 2011, 7 
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Tregs goes beyond the sole local suppressive activity 
and the delay of the onset of immune response. The 
IL-10,  TGF-β  and  CTLA-4  suppressive  environment 
probably  yields  “special”  conditions  that  favor  the 
expansion of antigen-specific Tregs, as seen in some 
trypanosome (T. congolense and T. cruzi) mouse mod-
els [83, 88]. In addition, T. cruzi trypomastigotes seem 
to be responsible for the generation of regulatory DC 
in vitro; in turn, these DCs induce Treg cells in vitro 
[87]. The mechanism may involve DC activation by 
the parasite, mediated by TLR4 and ERK, and is asso-
ciated to the yielding of high IL-10 levels [89]. Nev-
ertheless, the relevance of this phenomenon in Treg 
induction remains to be elucidated. 
In malaria 
Malaria  is  caused  by  infection  with  protozoan 
parasites  of  the  genus  Plasmodium.  After  infection, 
sporozoites move from the dermis to the liver, where 
they go through an asymptomatic stage of rapid divi-
sion before the parasite re-enters the bloodstream. In 
blood, exponential expansion of parasite populations 
leads  to  febrile  illness.  Typically,  acute  infection  is 
controlled and chronic infection is established at rea-
sonably low parasite density. However, in some cases 
the disease is lethal [90]. 
Infection with malaria parasites induces an im-
mune  response,  either  an  effector  or  a  suppressive 
one.  Treg  cells  induction  during  malaria  infection 
could be either beneficial or detrimental to the pro-
gression of the disease. Controversial results on the 
immunomodulatory  properties  of  parasite  compo-
nents  are  reported.  There  is  also  conflicting  infor-
mation about the role of Tregs in malaria infection. In 
mice  models,  Tregs  depletion  protects  experimental 
subjects from death when infected with a lethal strain 
of  Plasmodium  yoelii.  Additionally,  Tregs  depletion 
protects mice from Plasmodium falciparum in cerebral 
malaria (CM) [91-93]. In contrast, during CM associ-
ated with Plasmodium berghei or during infection with 
Plasmodium chabaudi,  Tregs  depletion  does  not  alter 
the parasitemia in mice [94-96]. These contradictory 
effects of Tregs in Plasmodium infection could be re-
lated to kinetic differences in the modulation of pro- 
and anti-inflammatory responses. Moreover, particu-
lar parameters such as mouse strain, age, sex, early 
cytokine profile production, and natural susceptibility 
to infection may influence the resulting role of Tregs. 
In spite of the contradictory evidence on the role 
of Treg cells on malaria infection, some results sug-
gest  the  Treg  cell  induction  by  Plasmodium.  In  fact, 
several reports demonstrate the increase of Tregs with 
suppressive capacity: Human infections with Plasmo-
dium falciparum and P. vivax induced a significant ex-
pansion of CD4+CD25+Foxp3+ Treg cells expressing 
the  key  immunomodulatory  molecule  CTLA-4  [97]. 
Also, a Treg increase in human cord blood was ob-
served  in  newborns  of  women  with  malaria;  these 
Tregs are able to suppress Th1-type recall responses 
[98].  In  addition,  an  increased  proportion  of  Tregs 
with suppressive functions has been observed in  P. 
yoelii and in P. berghei infected mice [95, 99-101]. The 
effect of this Treg increase at the beginning or during 
malaria progression needs to be clarified. 
Moreover,  malaria  infection  seemingly  drives 
Tregs generation/induction. Couper et al., 2007, have 
compared the depletion and repopulation  of spleen 
CD4+CD25+Foxp3+ Tregs in uninfected and malar-
ia-infected  mice.  By  adoptive  transfer,  they  have 
shown  that  repopulation  of  the  spleen  by 
CD25(high)Foxp3+  cells  results  from  the 
re-expression  of CD25 on  peripheral populations of 
CD25-Foxp3+.  Repopulation  of  the  spleen  by 
CD25+Foxp3+ cells occurs extremely rapidly in ma-
laria-infected  mice  when  compared  to  non-infected 
mice. Thus, malaria infection may drive proliferation 
and  CD25  expression  in  peripheral 
CD4+CD25-Foxp3+  cells  and/or  conversion  of 
CD4+CD25-Foxp3- cells [102]. 
On the other hand, T cell induction during ma-
laria may be cytokine-dependent (IL-10 and TGF-β). A 
correlation has been observed between Tregs and el-
evated IL-10 levels in susceptible mice, but not in re-
sistant mouse strains [101]. P. yoelii triggers Treg cell 
induction, probably mediated by TGF-β activation. In 
fact,  thrombospondin-like  molecules  and  metallo-
proteases present in P. yoelii extracts are able to acti-
vate latent  TGF-β  to  its  bioactive  form.  During  the 
priming  of  malaria-specific  T  cells,  TGF-β  might 
up-regulate  Foxp3,  leading  to  the  development  of 
regulatory T cells [103]. 
In humans, a P. falciparum-mediated conversion 
of CD4(+)CD25(-) T cells into CD25+Foxp3+CD4+ T 
cells has been described. Induction of Foxp3 cells in 
vitro required TGF-β1 and IL-10, and these cells show 
the  typical  suppressor  phenotype  (CTLA-4(+), 
CD127(low), CD39(+), ICOS(+), TNFRII(+))  [104]. In 
accordance, an increase in systemic IL-10 and TGF-β 
that  correlates  with  up-regulation  of 
CD4+CD25+Foxp3+  has  been  observed  in  humans 
infected with P. falciparum and P. vivax [105, 106]. 
The induction of Treg cells during malaria may 
imply dendritic cells. During Plasmodium yoelii infec-
tion,  regulatory  CD11clowCD45RBhigh  DCs  become 
prevalent in the spleen, overtaking the conventional 
CD11chigh  DCs.  Additionally,  regulatory 
CD11clowCD45RBhigh  DCs  induce  IL-10-expressing 
CD4  T  cell  [107].  In vivo experiments  demonstrated Int. J. Biol. Sci. 2011, 7 
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that during acute infection of P. yoelii, DCs migrate to 
the spleen and secrete TGF-β, prostaglandin E2 and 
IL-10. These DCs inhibit Plasmodium response, proba-
bly by generation of new Treg cells [108]. On the other 
hand, the pigment hemozoin (a metabolite from the 
parasite’s  intraerythrocytic  stage)  and  P.  falciparum 
merozoites promoted the generation of immunosup-
pressive  dendritic  cells.  The  maturation  of  human 
monocyte-derived dendritic cells (DCs) in vitro with 
hemozoin and merozoites prevented IL-12 production 
and augmented the release of IL-10 and TNFα. Addi-
tionally,  merozoites  prevented  soluble  CD40  lig-
and-induced  phenotypic  maturation  of  DCs  [109, 
110].  This  observation  suggests  that  hemozoin  and 
merozoites  induce  a  suppressive  DC  phenotype, 
which may play a role in favor of Treg cell induction. 
However,  the  immunosuppressive  properties  of 
hemozoin and merozoites remain uncertain. There are 
reports  concerning  the  immunosuppressive  proper-
ties of hemozoin and merozoites by inhibiting  den-
dritic cell activity (hemozoin reviewed in [111]) [110]. 
In  contrast,  other  authors  suggest  DC  activation  by 
these parasitic components [112-114]. Careful inves-
tigations are required to identify the molecule(s) re-
sponsible of modulating the DC function during ma-
laria and their role in Treg induction. 
On  the  other  hand,  it  has  been  described  that 
Treg cell induction can be a result of indirect interac-
tions during malaria infection. Scholzen et al. reported 
an  induction  of  human  CD25+Foxp3+  CD4  T  cells 
independent of MHCII interaction. Co-culture of the 
trophozoite-stage  malaria-infected  red  blood  cells 
with PBMC induces an enhancement of Treg levels. 
This induction seems not to be necessarily mediated 
by direct TCR stimulation, but could be mediated by 
soluble factors, including IL-2, IL-10, and TGF-β [104]. 
Also,  Hisaeda  observed  that  P. yoelii  induces  Tregs 
independently  of  MHCII  interaction.  Malaria  para-
sites interact with TLR9 in DCs to induce Tregs during 
infection  [115].  This  author  and  some  others  have 
proposed that merozoites/protein-DNA complexes or 
genetic  material  trapped  in  hemozoin  crystals  are 
ligands  for  TLR9  [112-115].  Thus,  TLR9  signaling 
might be a key factor for Treg induction [115] (Table 
4).  In  contrast,  other  authors  have  observed  that 
TLR9-deficient  mice  are  able  to  trigger  immune  re-
sponses, control the infection and clear the parasite 
[113, 116]. Although the latter studies did not report 
Treg levels, this finding indicate the need to further 
study the role of TLR9 during this parasitosis and its 
effect on Treg induction. 
 
Table 4. Regulatory T cells (Tregs) in malaria 
*Tr1: IL-10 producing cells, ‡Tregs: conventional Foxp3+ cells, ∞nTregs: Natural Tregs 
 
 
In nematode infections 
The filarial worm Onchocerca volvulus has been 
shown that induces immunosuppressive environment 
by cytokines such as IL-10 and TGF-β [117, 118]. In 
fact, infected patients has Tregs expressing CTLA-4 in 
onchocercomas lesion; and this cells are associated to 
immunosuppression  during  chronic  infection  [119]. 
Concordantly, hyper-reactive patients show reduced 
TGF-β expression [120] indicating that this cytokine 
may participate in down-regulating the immune re-
sponse. 
Other human and animal filarial diseases (Wu-
chereria bancrofti, Brugia malayi, Mansonella perstans and 
Parasites  Host  Molecule involved  Cells involved  Role of Tregs in pathogenesis  Ref # 
P. yoelii  Mouse  IL-10, TGF-β  ‡Tregs, *Tr1  Contribute to immune suppression, impede parasite 
clearance and promotes mice death 
[91, 146, 147] 
P. yoelii  Mouse  IL-10  Tregs  Suppress Th1 response early in the infection  [101, 147, 148] 
P. falciparum  Human  TGF-β,   Tregs   Increase in vivo parasite growth and disease severity  [105, 149] 
P. falciparum  Human  IL-10, CTLA-4  Tregs   Suppress Th1 response and favor placental infection  [150, 151]  
P. falciparum  Mouse  IL-10  Tregs  Modulate the pro- and anti-inflammatory responses 
affecting pathogenesis 
[92] 
P. berghei  Mouse    ∞nTregs  Suppress the Th1 response   [93, 100] 
P. berghei  Mouse    Tregs  No effect on cerebral malaria  [99] 
P. chabaudi  Mouse    nTregs  Control the secretion of pro-inflammatory cytokines  [95] 
P. vivax  Human  IL-10, TGF-β, GITR, 
CTLA-4 
Tregs  Increase parasite burden  [106] 
P. falciparum  Human  IL-10, TGF-β  Tregs  No effect on acute malarial inflammation Facilitate 
parasite clearance without causing immunopathology 
[152] 
P. yoelii  Mouse  TLR9  Tregs  Prevent anti-parasite immunity  [115] Int. J. Biol. Sci. 2011, 7 
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Litomosoides  sigmodontis)  promote  Treg  recruitment 
and increase Treg levels at the infection site (Table 5) 
[121-123]. In Brugia malayi infection (larvae and adult 
stages) there is immunomodulation associated to Treg 
expansion  and  to  an  increase  in  suppressive  mole-
cules such as TGF-β, CTLA-4, PD-1, ICOS, IDO [124, 
125].  During  L.  sigmodontis  infection,  Tregs  are  in-
creased both in acute and chronic infections [121, 126]. 
Taylor et al. observed that Treg depletion during  L. 
sigmodontis  infection  did  not  affect  larval  establish-
ment, but reduced the number of adult parasites [121]. 
Also,  in  W. bancrofti and M. perstans  infection,  Treg 
expansion  has  been  observed,  associated  to  an 
IL-10-dominated  regulatory  environment  [122].  A 
variety of events may contribute to activation or con-
trol of the immune response. In fact, not only parasite 
components may control the immune response, but 
also other factors affecting the parasite itself. As an 
example,  the  endosymbiont  Wolbachia  (a  bacterium 
living in filarial nematodes) is essential for the worm 
fertility and survival, and modulates the immune re-
sponse  in  patients  harboring  W. bancrofti.  In  fact,  a 
recombinant Wolbachia surface protein (WSP) induces 
suppressive  T  cell  response  in  Wuchereria  bancrofti 
infections. WSP components induce the expression of 
CTLA-4, IL-10, and TGF-β in PBMCs from filariasis 
patients [127]. This suggests that WSP may contribute 
to the suppression of the immune response in filaria-
sis patients, probably by Treg induction. 
Heligmosomoides  polygyrus,  a  gastrointestinal 
nematode, induces de novo Foxp3 expression in T cells 
and increases IL-10 and TGF-β levels; these induced 
Tregs express CD103 and CTLA-4 [128]. Additionally, 
induced Tregs have suppressive activity in vitro [128, 
129]. Rausch et al. have examined the role of effector 
and regulatory T cells during H. polygyrus infection by 
adoptive transfer. Their results show that while con-
ventional T effector cells conferred protection and led 
to a significant decrease in worm burdens, Tregs had 
no effect on worm burdens in the host. However, not 
long after infection, the number of Foxp3+ Treg cells 
temporarily increased in the inflamed tissue. On the 
other  hand,  the  transfer  of  a  heterogeneous  T-cell 
population containing Treg and T effector cells yields 
a  significant  decrease  in  worm  number  [129].  This 
study points out the importance of a balance between 
effector  and  regulatory  immune  response  to  deter-
minate the course of infection. 
 
Table 5. Regulatory T cells (Tregs) in nematode infections 
Parasites  Host  Molecule involved  Cells involved  Role of Tregs in pathogenesis  Ref # 
O. volvulus  Human  IL-10, TGF-β, CTLA-4  *Tr1  Tregs in onchocercomas are associated with immuno-
suppression during chronic infection. 
[119] 
L. sigmodontis  Mouse  IL-10, CTLA-4, GITR  ‡Tregs  No effect on larva establishment but favors chronicity. 
Inhibit protective immunity 
[121, 
126] 
L. sigmodontis  Mouse  TGF-β  Tregs   Induce unspecific suppression  [153] 
W. bancrofti and 
M. perstans 
Human  IL-10  ∞nTregs, Tr1  Induce a regulatory environment  [122] 
W. bancrofti  Human  §WSP, IL-10, TGF-β, 
CTLA-4 
T cell  Induce hypo-responsiveness in antigen-specific T cells  [127] 
B. malayi  Human  TGF-β, CTLA-4, PD-1, 
ICOS, IDO 
Tregs  Impairment of specific Th1 and Th2 immune response  [124] 
H. polygyrus  Mouse  IL-10, TGF-β, CTLA-4  Tregs  No effect on worm burdens  [129] 
H. polygyrus  Mouse  IL-10, TGF-β  Tregs  In vitro suppression of effector response  [128] 
H. polygyrus  Mouse  **HES   DC  Impairment of dendritic cell function and modulation of 
immune responses 
[131] 
H. polygyrus  Mouse  HES   Treg  Promote suppressive immune response  [132] 
*Tr1: IL-10 producing cells, ‡Tregs: conventional Foxp3+ cells, ∞nTregs: Natural Tregs, §WSP Wolbachia surface protein, **HES: Parasite 
excretory-secretory products. 
 
The mechanisms of Treg induction in nematode 
infections are not known. However, a mechanism for 
Treg  induction  by  Heligmosomoides  has  been  de-
scribed,  and  it  has  been  proposed  to  be  common 
among  nematodes.  On  one  side,  the  secreted  and 
constitutive  parasite  components  act  on  DCs  pro-
moting Treg generation. On the other side, secreted 
components  act  directly  on  T  lymphocytes  to  turn 
them into Tregs [130]. In fact, H. polygyrus produces in 
vitro  an  excretory-secretory  antigen  termed  HES.  It 
has been described that HES and an adult worm ho-
mogenate  (AWH)  inhibit  DC  activation,  cytokine 
(IL-12p70,  IL-6,  TNF-  and  IL-10)  and  chemokine 
(MCP-1,  and  RANTES)  production,  as  well  as 
co-stimulatory molecule expression (CD40, CD86 and 
MHC class II). Also, in DC HES induce the generation 
of CD4+CD25+ IL-10-producing T cells able to inhibit Int. J. Biol. Sci. 2011, 7 
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effector  T  cell  proliferation  and  IFN-  production 
[131]. 
With  regard  to  the  effect  of  HES  in  T  cells, 
Grainger et al. have described that HES is able to ligate 
directly to TGF-β receptor in T cells and promote a 
signaling pathway (Smad2/3 phosphorilation). Thus, 
HES triggers a TGF-β-like activity that mimics TGF-β 
functions.  More  interestingly,  HES  induces  de  novo 
Foxp3 expression in naïve T cells depending on sig-
naling  through  the  TGF-β  receptor.  To  confirm  the 
role of HES in Treg induction, the authors show that 
Foxp3 Treg cell conversion is enhanced in vivo by H. 
polygyrus infection [132]. The fact that nematodes se-
crete  a  TGF-β-like  molecule  suggests  that  parasites 
have  developed  strategies  to  circumvent  the  host’s 
immune response. These parasites have been learned 
during  millions  of  years  of  co-evolution  with  their 
hosts to identify molecules that promote Treg induc-
tion. 
Conclusions 
Parasites  use  all  the  mechanisms  herein  de-
scribed to induce Treg cells during their establishment 
and to promote their survival in the host. However, 
the structure and function of the parasite molecules 
involved  in  Treg  induction  is  just  partially  known. 
Many  parasitic  components  could  act  as  “cyto-
kine-like” or directly stimulate immune receptors; it is 
also  possible  that  parasite  molecules  act  directly  as 
Treg cell inducers. Some cases have been described in 
which a parasite molecule can use TLR4, TLR2 and 
TLR9 as intermediaries to induce Treg cells [89, 115, 
133]. In addition, parasites drive the cytokine balance 
during  infection  to  yield  an  environment  that  pro-
motes  Tregs  generation.  The  knowledge  on  the  im-
mune components and parasite molecules involved in 
controlling the immune response would be useful for 
a better understanding of the molecular mechanisms 
of Treg induction. Finally, the use of parasite mole-
cules to induce Tregs in vivo may provide a new al-
ternative to control inflammation in other diseases. 
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